rs768061768

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_003809.3(TNFSF12):​c.43G>A​(p.Glu15Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000378 in 1,310,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00037 ( 0 hom. )

Consequence

TNFSF12
NM_003809.3 missense

Scores

3
8
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 3.73

Publications

0 publications found
Variant links:
Genes affected
TNFSF12 (HGNC:11927): (TNF superfamily member 12) The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein is a ligand for the FN14/TWEAKR receptor. This cytokine has overlapping signaling functions with TNF, but displays a much wider tissue distribution. This cytokine, which exists in both membrane-bound and secreted forms, can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Alternative splicing results in multiple transcript variants. Some transcripts skip the last exon of this gene and continue into the second exon of the neighboring TNFSF13 gene; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13. [provided by RefSeq, Oct 2010]
TNFSF12-TNFSF13 (HGNC:33537): (TNFSF12-TNFSF13 readthrough) This gene encodes a member of the tumor necrosis factor superfamily. It encodes a hybrid protein composed of the cytoplasmic and transmembrane domains of family member 12 fused to the C-terminal domain of family member 13. The hybrid protein is membrane anchored and presents the receptor-binding domain of family member 13 at the cell surface. It stimulates cycling in T- and B-lymphoma cell lines. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004021287).
BS2
High AC in GnomAd4 at 61 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFSF12NM_003809.3 linkc.43G>A p.Glu15Lys missense_variant Exon 1 of 7 ENST00000293825.11 NP_003800.1
TNFSF12-TNFSF13NM_172089.4 linkc.43G>A p.Glu15Lys missense_variant Exon 1 of 11 NP_742086.1
TNFSF12NR_037146.2 linkn.139G>A non_coding_transcript_exon_variant Exon 1 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFSF12ENST00000293825.11 linkc.43G>A p.Glu15Lys missense_variant Exon 1 of 7 1 NM_003809.3 ENSP00000293825.6
TNFSF12-TNFSF13ENST00000293826.4 linkc.43G>A p.Glu15Lys missense_variant Exon 1 of 11 1 ENSP00000293826.4

Frequencies

GnomAD3 genomes
AF:
0.000402
AC:
61
AN:
151928
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000590
Gnomad ASJ
AF:
0.00692
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000579
AC:
2
AN:
3454
AF XY:
0.000449
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00935
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000375
AC:
434
AN:
1158762
Hom.:
0
Cov.:
31
AF XY:
0.000404
AC XY:
225
AN XY:
557608
show subpopulations
African (AFR)
AF:
0.000342
AC:
8
AN:
23382
American (AMR)
AF:
0.000991
AC:
9
AN:
9086
Ashkenazi Jewish (ASJ)
AF:
0.00716
AC:
113
AN:
15772
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26972
South Asian (SAS)
AF:
0.00
AC:
0
AN:
40654
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
26590
Middle Eastern (MID)
AF:
0.00251
AC:
8
AN:
3182
European-Non Finnish (NFE)
AF:
0.000255
AC:
246
AN:
965904
Other (OTH)
AF:
0.00106
AC:
50
AN:
47220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
32
65
97
130
162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000402
AC:
61
AN:
151928
Hom.:
0
Cov.:
32
AF XY:
0.000404
AC XY:
30
AN XY:
74218
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41384
American (AMR)
AF:
0.000590
AC:
9
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00692
AC:
24
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5146
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
67934
Other (OTH)
AF:
0.00191
AC:
4
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000624
Hom.:
0
Bravo
AF:
0.000635
ExAC
AF:
0.000441
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

See cases Uncertain:1
Jul 09, 2020
New York Genome Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Common variable immunodeficiency Uncertain:1
Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 15 of the TNFSF12 protein (p.Glu15Lys). This variant is present in population databases (rs768061768, gnomAD 0.6%). This variant has not been reported in the literature in individuals affected with TNFSF12-related conditions. ClinVar contains an entry for this variant (Variation ID: 526011). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.040
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.45
T;.
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.011
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Uncertain
0.86
D;D
MetaRNN
Benign
0.0040
T;T
MetaSVM
Uncertain
0.62
D
MutationAssessor
Uncertain
2.1
M;.
PhyloP100
3.7
PrimateAI
Pathogenic
0.82
D
PROVEAN
Benign
-0.61
N;N
REVEL
Uncertain
0.43
Sift
Pathogenic
0.0
D;D
Sift4G
Benign
0.21
T;T
Polyphen
0.32
B;.
Vest4
0.24
MutPred
0.24
Gain of MoRF binding (P = 0.0109);Gain of MoRF binding (P = 0.0109);
MVP
0.15
MPC
0.49
ClinPred
0.26
T
GERP RS
4.1
PromoterAI
-0.056
Neutral
Varity_R
0.33
gMVP
0.22
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768061768; hg19: chr17-7452513; API